Related Experiment Videos
Lessons from the TAPS study. Warfarin: a major cause of threats to patient safety
Meredith A B Makeham1, Deborah C Saltman, Michael R Kidd
1School of Public Health and Community Medicine, University of New South Wales. m.makeham@unsw.edu.au
Abstract:
The Threats to Australian Patient Safety (TAPS) study collected 648 anonymous reports about threats to patient safety from a representative random sample of Australian general practitioners. These contained any events the GPs felt should not have happened, and would not want to happen again, regardless of who was at fault or the outcome of the event. This series of articles presents clinical lessons resulting from the TAPS study.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pharmaceutical Poisoning: Potential Scenarios
Venous Thrombosis IV: Nursing Management
Errors occurring during blood pressure monitoring
Several factors...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Therapeutic Drug Monitoring: Affecting Factors